You have 9 free searches left this month | for more free features.

Ammonia N 13 Injection, USP

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by

Recruiting
  • Myocardial Ischemia
  • +7 more
  • Myocardial Perfusion Imaging Study
  • AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
  • Miami, Florida
  • +3 more
Jan 4, 2023

N-13 Ammonia Safety Trial in Montréal (N-13 ammonia intravenous injection)

Recruiting
  • N-13 Ammonia Safety
  • N-13 ammonia intravenous injection
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'université de Montréal
Aug 5, 2022

Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)

Not yet recruiting
  • Sickle Cell Disease
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT

Completed
  • Coronary Artery Disease
  • Cardiac Perfusion Rest/Stress Digital PET/CT
  • +2 more
  • Stanford, California
    Stanford University
Oct 24, 2021

Biomarkers of Risk of Parkinson Disease

Active, not recruiting
  • Parkinson Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2023

Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar, 13N-ammonia)

Recruiting
  • Coronary Artery Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 20, 2022

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)

Recruiting
  • Pharmacokinetics
  • +2 more
  • 5-methoxy-N,N-dimethyltryptamine succinate salt
  • Placebo
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc
Jan 13, 2023

Myocardial Infarction, Coronary Microvascular Dysfunction, Vasospasm, Coronary Trial in Gwangju (Intravascular imaging (OCT),

Recruiting
  • Myocardial Infarction
  • +2 more
  • Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)
  • Gwangju, Korea, Republic of
    Chonnam National University Hospital
Mar 13, 2022

Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2 Trial in Ottawa (drug,

Recruiting
  • Chronic Right-Sided Heart Failure
  • +5 more
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Nov 19, 2021

Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)

Terminated
  • Microvascular Coronary Artery Disease
  • Los Angeles, California
  • +9 more
Mar 15, 2022

Coronary Disease Trial in Beijing (18F-FMPP)

Unknown status
  • Coronary Disease
  • Beijing, Dongcheng, China
    Peking union medical college hospital
Oct 21, 2020

Liver Tumor, Liver Tumors Trial in Boston (N-13 ammonia or F-18 fluorodeoxyglucose, PET scan)

Completed
  • Liver Tumor
  • Liver Neoplasms
  • N-13 ammonia or F-18 fluorodeoxyglucose
  • PET scan
  • Boston, Massachusetts
  • +1 more
Mar 4, 2020

Refralon®, Concentrate for Solution for Intravenous Injection in

Recruiting
  • Paroxysmal Atrial Fibrillation
  • +2 more
  • Ufa, Bashkortostan Republic, Russian Federation
  • +31 more
Mar 6, 2023

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Single Rest-Stress Imaging Protocol for Myocardial Perfusion

Recruiting
  • Coronary Artery Disease
  • Myocardial Ischemia
  • Single-Scan Two-Injection Protocol
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 15, 2022

Ureter Injury Trial (Saline Injection 0.9%, Indigotindisulfonate sodium 0.8%)

Not yet recruiting
  • Ureter Injury
  • Saline Injection 0.9%
  • Indigotindisulfonate sodium 0.8%
  • (no location specified)
Oct 12, 2023

Shoulder Impingement Syndrome, Adhesive Capsulitis of Shoulder Trial in Chuncheon (Ultrasound-guided glenohumeral space

Completed
  • Shoulder Impingement Syndrome
  • Adhesive Capsulitis of Shoulder
  • Ultrasound-guided glenohumeral space triamcinolone, lidocaine and saline injection
  • Ultrasound-guided subacromial space triamcinolone, lidocaine and saline injection
  • Chuncheon, Gangwondo, Korea, Republic of
    Chuncheon Sacred Heart Hospital
Sep 21, 2023

Liver Failure, Acute Trial in New Delhi (L-ornithine L-Aspartate, Placebo)

Not yet recruiting
  • Liver Failure, Acute
  • L-ornithine L-Aspartate
  • Placebo
  • New Delhi, India
    Institute of Liver and Biliary Sciences
Mar 9, 2023

Toxic Effect of Organophosphate and Carbamate Insecticides Trial in High Point (Atropine Sulfate Ophthalmic Solution, Atropine

Completed
  • Toxic Effect of Organophosphate and Carbamate Insecticides
  • Atropine Sulfate Ophthalmic Solution
  • Atropine Sulphate Injection
  • High Point, North Carolina
    High Point Clinical Trials Center
Jul 20, 2021

Ornithine Transcarbamylase Deficiency Trial (AAVLK03hOTC)

Not yet recruiting
  • Ornithine Transcarbamylase Deficiency
  • AAVLK03hOTC
  • (no location specified)
Oct 21, 2021

Acute Coronary Syndrome Trial (index of microcirculatory resistance)

Completed
  • Acute Coronary Syndrome
  • index of microcirculatory resistance
  • (no location specified)
Nov 17, 2019

Chronic Heart Failure With Reduced Ejection Fraction Trial in Hungary, Poland, United States (IONIS-AGT-LRx, Placebo)

Active, not recruiting
  • Chronic Heart Failure With Reduced Ejection Fraction
  • Little Rock, Arkansas
  • +25 more
Jul 27, 2022

Palliative Care in COVID-19: Analysis of Costs of

Not yet recruiting
  • COVID-19
  • Palliative Care
  • Analysis of costs with patient care during hospitalization
  • (no location specified)
Jun 12, 2023